Ondansetron/Cyclodextrin inclusion complex nanofibrous webs for potential orally fast-disintegrating antiemetic drug delivery
buir.contributor.author | Durgun, Engin | |
buir.contributor.orcid | Durgun, Engin|0000-0002-0639-5862 | |
dc.citation.epage | 121921-12 | en_US |
dc.citation.spage | 121921-1 | en_US |
dc.citation.volumeNumber | 623 | en_US |
dc.contributor.author | Hsiung, E. | |
dc.contributor.author | Celebioglu, A. | |
dc.contributor.author | Emin Kilic, M. | |
dc.contributor.author | Durgun, Engin | |
dc.date.accessioned | 2023-02-24T13:04:41Z | |
dc.date.available | 2023-02-24T13:04:41Z | |
dc.date.issued | 2022-07-25 | |
dc.department | Institute of Materials Science and Nanotechnology (UNAM) | en_US |
dc.description.abstract | Ondansetron (ODS) is an effective antiemetic drug which suffers from limited solubility and bioavailability during oral administration due to first-pass metabolism. However, these limitations can be mitigated through inclusion complexation with cyclodextrins (CDs). In this study, we have reported the electrospinning of polymer-free, free-standing ODS/CD nanofibrous webs (NW), a promising approach for developing a fast-disintegrating delivery system of an antiemetic drug molecule. Highly water soluble hydroxypropyl-beta-cyclodextrins (HPβCD) were used as both complexation agent and electrospinning matrix. The computational study revealed that the 1/2 (drug/CD) stoichiometry was more favorable compared to 1/1. The ODS/HPβCD NW was obtained with higher loading efficiency (∼96 %) compared to the control sample of ODS/polyvinyl alcohol (PVA) NW (∼80 %). The amorphous distribution of ODS raised by complexation and the highly water-soluble nature of HPβCD resulted into faster and better release profile and quite faster disintegration property (∼2 s) in artificial saliva than polymeric ODS/PVA NW. Here, ODS/HPβCD NW was generated in the absence of a toxic solvent or chemical to enable the drug loading in an amorphous state. From all reasons above, ODS/HPβCD NW might be a promising alternative to the polymeric based systems for the purpose of fast-disintegrating oral drug delivery. | en_US |
dc.description.provenance | Submitted by Bilge Kat (bilgekat@bilkent.edu.tr) on 2023-02-24T13:04:41Z No. of bitstreams: 1 Ondansetron-Cyclodextrin_inclusion_complex_nanofibrous_webs_for_potential_orally_fast-disintegrating_antiemetic_drug_delivery.pdf: 9711743 bytes, checksum: ae6a13d9dce24a3a46f47ccfbca05e8e (MD5) | en |
dc.description.provenance | Made available in DSpace on 2023-02-24T13:04:41Z (GMT). No. of bitstreams: 1 Ondansetron-Cyclodextrin_inclusion_complex_nanofibrous_webs_for_potential_orally_fast-disintegrating_antiemetic_drug_delivery.pdf: 9711743 bytes, checksum: ae6a13d9dce24a3a46f47ccfbca05e8e (MD5) Previous issue date: 2022-07-25 | en |
dc.identifier.doi | 10.1016/j.ijpharm.2022.121921 | en_US |
dc.identifier.eissn | 1873-3476 | |
dc.identifier.issn | 0378-5173 | |
dc.identifier.uri | http://hdl.handle.net/11693/111691 | |
dc.language.iso | English | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | https://doi.org/10.1016/j.ijpharm.2022.121921 | en_US |
dc.source.title | International Journal of Pharmaceutics | en_US |
dc.subject | Electrospinning | en_US |
dc.subject | Cyclodextrin | en_US |
dc.subject | Ondansetron | en_US |
dc.subject | Fast disintegrating | en_US |
dc.subject | Oral drug delivery | en_US |
dc.subject | Antiemetic treatment | en_US |
dc.title | Ondansetron/Cyclodextrin inclusion complex nanofibrous webs for potential orally fast-disintegrating antiemetic drug delivery | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Ondansetron-Cyclodextrin_inclusion_complex_nanofibrous_webs_for_potential_orally_fast-disintegrating_antiemetic_drug_delivery.pdf
- Size:
- 9.26 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.69 KB
- Format:
- Item-specific license agreed upon to submission
- Description: